Triumph Over Adversity: A Heartfelt Journey of an HIV Survivor Celebrating 25 Years of Resilience
Recently, Dr. Ishwar Gilada celebrated a remarkable milestone at his HIV and infectious diseases clinic in Mumbai-a 25-year journey of survival for a patient who once arrived in dire condition. Back in 1999, this man was brought to the clinic in a wheelchair, semi-comatose, and barely responsive. His situation appeared desperate. Yet, 25 years later, he greeted staff with a smile, standing tall at 60, a testament to the resilience of the human spirit.
Referred by family physician Dr. Shyam Pophale from Goregaon, Mumbai, the patient showed signs of severe deterioration when he first attended the clinic. His health had declined over months, initially presenting as unsteadiness and slurred speech, eventually leading to profound unresponsiveness. He had recently tested positive for HIV and was a father of a two-year-old daughter, with a wife who remained HIV-negative.
Upon examination, the clinic’s tests revealed alarming statistics: a CD4 count of merely 12, far below the normal range of 500 to 1600, and a viral load of over 2.1 million copies per milliliter, indicating a nearly destroyed immune system. Initially suspecting common HIV-related infections like toxoplasmosis or tubercular meningitis, doctors were puzzled when the patient displayed none of the typical symptoms associated with those conditions.
An MRI scan, however, uncovered lesions in the white matter of both sides of the brain, providing insight into a rare and often fatal illness called Progressive Multifocal Leukoencephalopathy (PML). This condition, triggered by the JC virus, typically remains harmless until the immune system falters. In 1999, diagnosing PML relied heavily on clinical judgment, as modern testing methods like PCR were not widely available.
The patient was admitted to Bombay Hospital under the care of noted neurologist Dr. B.S. Singhal, who would later receive the Padma Shri in 2022. At that time, no direct cure existed for PML, leaving treatment options limited to aggressive management of HIV and symptom relief. Dr. Gilada’s team employed a combination of Indinavir, Zidovudine, and Lamivudine, antiretroviral drugs known to penetrate effectively into the brain. These drugs do not eradicate HIV but inhibit its replication, allowing the immune system a chance to recover and combat secondary infections like PML.
Despite the family’s anxiety about the prognosis, hope remained. Remarkably, within three weeks of initiating treatment, the patient began showing signs of improvement. His speech returned-albeit with a stutter-and he slowly regained mobility. His gradual recovery involved extensive support and monitoring, reestablishing connections with his family.
Today, at 60, he enjoys a stable and fulfilling life. Unfortunately, his wife, who remained HIV-negative, passed away a few years ago due to a heart condition. Their daughter, once a toddler, is now 28 years old and recently married. Through careful precautions and some luck, the patient’s wife avoided transmission, highlighting the fact that not all spouses of HIV-positive individuals become infected. With modern antiretroviral therapy (ART), patients can achieve an undetectable viral load, resulting in a principle known as “Undetectable = Untransmittable” (U=U), which assures that the virus cannot be passed to a partner or child.
Dr. Gilada underscores the broader implications of this story. Out of nearly 7,500 individuals living with HIV under his care, they have treated close to 50 cases of PML. Although some patients have succumbed, many have defied the odds, benefiting from advances in HIV treatment that target the brain more effectively. He emphasizes that, with early diagnosis and intervention, people living with HIV can lead near-normal lifespans.
This patient’s journey illustrates the profound impact of dedicated medical care and the importance of vigilance not only for individuals living with HIV but for their families as well. Dr. Gilada remains committed to spreading awareness about the complexities of HIV, reinforcing that health vigilance must encompass the entire family.
Original Source: https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/from-deaths-door-to-25-yrs-on-hiv-survivors-second-chance/articleshow/124882211.cms
Category :
Tags:
Publish Date: 2025-10-29 03:00:00
